Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2021-07-06 5:01 pm Purchase |
2021-06-25 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
BIOTECHNOLOGY VALUE FUND L P | 2,005,862 7.500% |
2,005,862![]() (New Position) |
Filing History |
2021-05-25 5:22 pm Purchase |
2021-05-21 | 13D | Rain Enhancement Technologies Holdco Inc RAIN |
BIOTECHNOLOGY VALUE FUND L P | 1,945,949 13.000% |
93,438![]() (+5.04%) |
Filing History |
2021-05-17 4:49 pm Purchase |
2021-05-06 | 13G | Revolution Medicines, Inc. RVMD |
BIOTECHNOLOGY VALUE FUND L P | 3,757,049 5.100% |
3,757,049![]() (New Position) |
Filing History |
2021-05-03 5:19 pm Sale |
2021-04-29 | 13G | CytomX Therapeutics, Inc. CTMX |
BIOTECHNOLOGY VALUE FUND L P | 2,919,471 4.500% |
-2,657,000![]() (-47.65%) |
Filing History |
2021-04-29 4:29 pm Sale |
2021-04-27 | 13G | IDEAYA Biosciences, Inc. IDYA |
BIOTECHNOLOGY VALUE FUND L P | 1,787,559 5.400% |
-1,439,210![]() (-44.60%) |
Filing History |
2021-04-28 09:26 am Purchase |
2021-04-23 | 13D | Rain Enhancement Technologies Holdco Inc RAIN |
BIOTECHNOLOGY VALUE FUND L P | 1,852,511 13.000% |
1,852,511![]() (New Position) |
Filing History |
2021-04-15 4:11 pm Purchase |
2021-04-13 | 13G | Ovid Therapeutics Inc. OVID |
BIOTECHNOLOGY VALUE FUND L P | 6,631,051 10.100% |
2,109,000![]() (+46.64%) |
Filing History |
2021-04-15 4:06 pm Purchase |
2021-04-13 | 13G | ContraFect Corporation CFRX |
BIOTECHNOLOGY VALUE FUND L P | 49,654 10.100% |
13,292![]() (+36.56%) |
Filing History |
2021-04-05 5:03 pm Purchase |
2021-03-26 | 13G | Ikena Oncology, Inc. IKNA |
BIOTECHNOLOGY VALUE FUND L P | 1,599,658 5.100% |
1,599,658![]() (New Position) |
Filing History |
2021-04-02 5:16 pm Sale |
2021-03-31 | 13D | XOMA Corporation XOMA |
BIOTECHNOLOGY VALUE FUND L P | 3,530,543 31.400% |
-651,700![]() (-15.58%) |
Filing History |
2021-03-16 5:18 pm Purchase |
2021-03-12 | 13G | Repare Therapeutics Inc. RPTX |
BIOTECHNOLOGY VALUE FUND L P | 3,722,398 10.100% |
750,207![]() (+25.24%) |
Filing History |
2021-03-15 07:55 am Purchase |
2021-03-10 | 13D | CTI BioPharma Corp. CTIC |
BIOTECHNOLOGY VALUE FUND L P | 17,123,023 19.990% |
4,369,333![]() (+34.26%) |
Filing History |
2021-03-09 9:40 pm Unchanged |
2021-03-08 | 13G | PHAXIAM Therapeutics S.A. PHXM |
BIOTECHNOLOGY VALUE FUND L P | 40,819 19.300% |
0 (Unchanged) |
Filing History |
2021-03-08 4:54 pm Purchase |
2021-03-04 | 13G | FIVE PRIME THERAPEUTICS INC FPRX |
BIOTECHNOLOGY VALUE FUND L P | 6,338,678 13.800% |
3,200,000![]() (+101.95%) |
Filing History |
2021-03-05 4:33 pm Purchase |
2020-10-14 | 13G | 5:01 Acquisition Corp. FVAM |
BIOTECHNOLOGY VALUE FUND L P | 500,000 5.800% |
500,000![]() (New Position) |
Filing History |
2021-02-19 5:10 pm Unchanged |
2021-02-17 | 13G | Infinity Pharmaceuticals, Inc. INFIQ |
BIOTECHNOLOGY VALUE FUND L P | 8,383,645 9.960% |
0 (Unchanged) |
Filing History |
2021-02-16 4:30 pm Sale |
2021-02-11 | 13D | Infinity Pharmaceuticals, Inc. INFIQ |
BIOTECHNOLOGY VALUE FUND L P | 8,383,645 13.100% |
-2,343,323![]() (-21.85%) |
Filing History |
2021-02-16 4:17 pm Sale |
2020-12-31 | 13G | NOVUS THERAPEUTICS INC NVUS |
BIOTECHNOLOGY VALUE FUND L P | 1,503,121 9.990% |
-14,918![]() (-0.98%) |
Filing History |
2021-02-12 9:17 pm Purchase |
2020-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
BIOTECHNOLOGY VALUE FUND L P | 4,274,965 9.990% |
1,942,335![]() (+83.27%) |
Filing History |
2021-02-12 8:57 pm Purchase |
2020-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
BIOTECHNOLOGY VALUE FUND L P | 57,321 9.990% |
1,971![]() (+3.56%) |
Filing History |